Filter
857
Text search:
pharmaceutical
regulations
Featured
Recommendations
70
New Publications
238
Language
Document type
No document type
425
Studies & Reports
168
Guidelines
141
Manuals
46
Strategic & Response Plan
45
Training Material
11
Fact sheets
10
Situation Updates
6
Resource Platforms
3
Brochures
1
Infographics
1
Countries / Regions
Kenya
48
Global
28
India
26
Western and Central Europe
26
Nigeria
24
South Africa
23
Sierra Leone
22
Ethiopia
21
Uganda
19
Liberia
18
Ghana
18
Nepal
18
Tanzania
17
Rwanda
17
Zambia
13
Eastern Europe
13
Africa
12
Philippines
11
Indonesia
11
Bangladesh
10
Lesotho
10
Zimbabwe
9
Namibia
9
Myanmar / Burma
9
Malawi
8
Ukraine
7
South–East Asia Region
7
Latin America and the Carribbean
7
Cambodia
6
Eswatini/ Swaziland
6
West and Central Africa
6
Senegal
5
Thailand
5
Botswana
5
Eastern Europe and Central Asia
5
Cameroon
4
Syria
4
East and Southern Africa
4
Western Pacific Region
4
Burkina Faso
3
Haiti
3
Pakistan
3
Mozambique
3
Brazil
3
Laos
3
Russia
3
Guinea
2
Congo, Democratic Republic of
2
Mali
2
China
2
Sudan
2
North Macedonia
2
Middle East and North Africa
2
Asia
2
Fiji
2
Tajikistan
2
Kyrgyzstan
2
Vietnam
2
Somalia
1
South Sudan
1
Iraq
1
Jordan
1
Afghanistan
1
Germany
1
Chad
1
Papua New Guinea
1
Benin
1
Central African Republic
1
Peru
1
Serbia
1
El Salvador
1
Angola
1
Chile
1
Albania
1
Armenia
1
Canada
1
Timor Leste/ East Timor
1
Lithuania
1
Iran
1
Uzbekistan
1
Australia
1
Kazakhstan
1
Georgia
1
Gabon
1
Turkmenistan
1
Denmark
1
Maldives
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
388
Clinical Guidelines
35
Key Resources
31
Public Health
29
Pharmacy & Technologies
23
Women & Child Health
13
Capacity Building
6
Toolboxes
AMR
137
Pharmacy
91
COVID-19
73
Rapid Response
35
Mental Health
35
TB
30
HIV
29
Planetary Health
18
Caregiver
17
Ebola
14
Global Health Education
12
Health Financing Toolbox
11
Conflict
10
NTDs
8
NCDs
8
Specific Hazards
6
Disability
5
Polio
2
Natural Hazards
2
Zika
2
Cholera
1
Refugee
1
Health Financing
1
Official Gazette No Special of 17/01/2013 | LAW No 47/2012 OF 14/01/2013 RELATING TO THE REGULATION AND INSPECTION OF FOOD AND PHARMACEUTICAL PRODUCTS
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covi
...
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a disease or reduction of its effectiveness in improv
...
The purpose of this document is to provide relevant information and guidelines on
coronavirus outbreaks – and in particular the novel coronavirus SARS-CoV-2 and the
diseases it produces, COVID-19 – for pharmacists and the pharmacy workforce, both in a
primary care context (i.e. community phar
...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202
...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202
...
The purpose of these guidelines is to help health workers to participate in the process of continuous surveillance of safety and efficacy of the pharmaceutical products which are used in clinical practice, thus help to achieve the ultimate goal to m
...
N°46/2012 of 14/01/2013 - Official Gazette n° Special of 17/01/2013 - LAW No 45/2012 OF 14/01/2013 ON ORGANISATION, FUNCTIONING AND COMPETENCE OF THE COUNCIL OF PHARMACISTS
The increasing global trend of Antimicrobial resistance (AMR) has gradually emerged as a major public health challenge for the entire world. AMR has spread to almost all countries and regions, including Pakistan owing to the “misuse and overuse” of Antimicrobials, contributing to the increasing
...
PQM conducted an assessment of the medicine quality assurance and quality control systems in Rwanda during November 9-13, 2009. Medicine quality assurance remains to be developed in Rwanda: the country has neither a medicine regulatory authority (MRA) nor a national medicine quality control laborato
...
GOVERNMENT NOTICE | No. 192 Promulgation of Medicines and Related Substances Control Act, 2003 (Act No. 13 of 2003), of the Parliament
WHO Technical Report Series, No. 961, 2011, Annex 8 - These guidelines are intended to provide a description of ways in which pharmacists can improve access to health care, health promotion and the use of medicines on behalf of the patients they serve. The role of FIP is to provide leadership for na
...
Good Manufacturing Practice (GMP) describes a set of principles and procedures that, when followed, ensure that medicines and related substances are of high quality, safety and efficacy. SAHPRA is a
participating authority of the Pharmaceutical Ins
...
This field study to measure access to and use of medicines was undertaken in GHANA in May-June 2008. The study assessed information on the socio-economic level of households, and access to and use of medicines for acute and chronic conditions as well as opinions and perceptio
...
